PolyPid
PYPD
27 hedge funds and large institutions have $8.71M invested in PolyPid in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
42% more funds holding
Funds holding: 19 → 27 (+8)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% less ownership
Funds ownership: 0.27% → 0.27% (-0%)
27% less capital invested
Capital invested by funds: $11.9M → $8.71M (-$3.19M)
59% less call options, than puts
Call options by funds: $153K | Put options by funds: $370K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$500K |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$228K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$178K |
| 4 |
Morgan Stanley
New York
|
+$111K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$110K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
-$1.09M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$456K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$112K |
| 4 |
1C
1623 Capital
Alexandria,
Virginia
|
-$90K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$18.4K |
PYPD Hedge Fund Activity: Q4 2021 in Review
27 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q4 2021, worth a combined $8.71M — down 27% from $11.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PYPD positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $500K. The largest seller was Moore Capital Management, cutting an estimated $1.09M.
- 27 institutional investors held PolyPid (PYPD) as of Q4 2021, up from 19 in Q3 2021.
- Funds reported $8.71M of PolyPid stock for Q4 2021, down 27% quarter-over-quarter.
- 9 funds opened new PolyPid positions in Q4 2021 and 1 closed out, a net change of +8 holders.
- The largest PolyPid buyer in Q4 2021 was Barclays, an estimated $500K added.
- The largest PolyPid seller in Q4 2021 was Moore Capital Management, an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2021.